Subscribe to receive our latest press releases.

 

 

Below you will find all our press releases. Simply click on the year that interests you to view the documents.

2019

Aug 22 - Neptune creates two new roles to support its expansionAug 15 - Neptune Announces the Election of its Directors and Voting ResultsAug 14 - Neptune announces First Quarter ResultsJuly 29 - Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30, 2019July 24 - Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction CapabilitiesJuly 18 - Neptune Wellness Solutions Closes US$41 Million Private PlacementJuly 8 - Neptune Appoints Michael Cammarata as Chief Executive OfficerJune 17 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Receives Health Canada’s Amendments to Expand Capacity to 200,000 kg and for Cannabis Oil Capsule ProductionJune 12 - Neptune Announces Fourth Quarter ResultsJune 12 - Neptune Signs Multi-Year Extraction Agreement for 230,000 kg Including Turnkey Solutions with The Green Organic DutchmanJune 7 - Neptune signs multi-year extraction agreement with TilrayMay 30 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2019May 13 - Neptune Welcomes Martin Landry as Chief of Corporate Development & StrategyMay 10 - Neptune Settles On Claims on Employment Contract By Former Chief Executive OfficerMay 9 - Neptune Signs definitive agreement to acquire the assets of Hemp processor SugarLeaf LabsMay 1 - Neptune to Present at May 2019 ConferencesApr. 15 - Neptune Expands Existing Offering of Turnkey Solutions in the U.S. to Include Hemp IngredientsApr. 10 - Neptune Welcomes Dr. Graham Wood as Chief Scientific OfficerApr. 4 - Neptune to present at 2019 GMP Securities Cannabis ConferenceMar. 26 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Begins Commercial Production and Shipping of Cannabis ExtractsMar. 25 - Neptune Receives Judgment On Claims By Former Chief Executive OfficerFeb. 13 - Neptune Annouces it Third Quarter ResultsJan. 29 - Neptune to Hold Conference Call to Discuss Third Quarter Results for the Three Months Period Ended December 31, 2018Jan. 7 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., receives license to process cannabis from Health CanadaAug 14 - Neptune announces First Quarter Results

2018

Dec. 21 - Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in CanadaNov. 26 - Neptune to Participate in Fall 2018 Investor ConferencesNov. 13 - Neptune Announces Second Quarter ResultsOct. 31 - Neptune to Hold Conference Call to Discuss Second Quarter Results for the Three Months Period Ended September 30, 2018 Laval,Oct. 23 - Neptune to exhibit and present at 2018 Montreal Cannabis ExpoSept. 27 - Appointment of Caroline Lavoie and Evidence package submitted to Health CanadaSept. 20 - Neptune to Present at Sidoti & Company Fall 2018 ConferenceSept. 19 - Neptune Confirms its Name Change to Neptune Wellness Solutions Inc.Sept. 17 - Neptune Receives Confirmation of Readiness Letter from Health CanadaAug. 16 - Neptune Announces Appointment of Hélène F. Fortin to its Board of DirectorsAug. 15 - Neptune Announces the Election of its Directors and Voting ResultsAug. 14 - Neptune Announces First Quarter ResultsAug. 9 - Cannabis Patent ApplicationsJul. 31 - Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30th, 2018Jun. 19 - Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis ProductsJun. 5 - Neptune Announces Fourth Quarter and Year-end ResultsMar. 31 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018Feb. 14 - Neptune Announces Third Quarter ResultsFeb. 12 - Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and InflammationJan. 31 - Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017Jan. 19 - Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based ProductsJan. 17 - Neptune makes its recommendations on Bill 157 special consultations at the National Assembly

2017

Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid RequirementsHighlights of Neptune’s Investor Conference Being Held in New York TodayNeptune Extends Global MaxSimil® Licence To Cannabis-Derived ProductsNeptune Announces Second Quarter ResultsNeptune to Hold Business Update Meeting on November 28, 2017Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017Neptune announces appointments for its Cannabis BusinessNeptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as ChairmanNeptune to Hold Conference Call to Discuss the Transaction with Aker BioMarineAker BioMarine and Neptune announce closing of $US34 million transaction to accelerate business and industry developmentNeptune Receives Nasdaq Notification Regarding Minimum Bid RequirementsNeptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017Neptune Announces 4-Month Period and 13-Month Period ResultsNeptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017Unique Medical Cannabis Partnership Announced, Creating Scientific and Business Development Hub in Sherbrooke, QuebecNeptune enters into Commercial Distribution Joint Venture in China with Shanghai Chonghe Marine Industry Co., Ltd.Neptune and Enzymotec Reach Patent Agreement Ending All Litigation

2016